Natural Killer Cell Receptors and Endometriosis: A Systematic Review
This systematic review of 18 studies found that endometriosis pathogenesis involves overexpression of NK inhibitory receptors and decreased NK activating receptors, suggesting NK receptor activity influences clearance of endometriotic cells.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (38)
- Aberrant Expression of CD95 and CD69 Molecules among CD56<sup>+</sup> Cells in Women with Endometriosis via openalex
- Aberrant expression of intercellular adhesion molecule-1 and killer inhibitory receptors induces immune tolerance in women with pelvic endometriosis via openalex
- Co-expression of activating and inhibitory receptors on peritoneal fluid NK cells in women with endometriosis via openalex
- Expression of Natural Cytotoxicity Receptors on Peritoneal Fluid Natural Killer Cell and Cytokine Production by Peritoneal Fluid Natural Killer Cell in Women with Endometriosis via openalex
- Expression of programmed death-1 (PD-1) and its ligand PD-L1 is upregulated in endometriosis and promoted by 17beta-estradiol via openalex
- Expressions of natural cytotoxicity receptor, NKG2D and NKG2D ligands in endometriosis via openalex
- Histocompatibility leukocyte antigen-G is not expressed by endometriosis or endometrial tissue via openalex
- HLA-G is expressed by the glandular epithelium of peritoneal endometriosis but not in eutopic endometrium via openalex
- HLA-G is upregulated in advanced endometriosis via openalex
- Immunology of endometriosis via openalex
- Increased frequency of human leukocyte antigen–E inhibitory receptor CD94/NKG2A–expressing peritoneal natural killer cells in patients with endometriosis via openalex
- Increased killer inhibitory receptor KIR2DL1 expression among natural killer cells in women with pelvic endometriosis via openalex
- Increase in the expression of killer cell inhibitory receptors on peritoneal natural killer cells in women with endometriosis via openalex
- Killer cell immunoglobulin-like receptors (KIR) and human leukocyte antigen-C (HLA-C) allorecognition patterns in women with endometriosis via openalex
- Killer Inhibitory Receptor CD158a Overexpression Among Natural Killer Cells in Women With Endometriosis is Undiminished by Laparoscopic Surgery and Gonadotropin Releasing Hormone Agonist Treatment* via openalex
- Metastatic or Embolic Endometriosis, due to the Menstrual Dissemination of Endometrial Tissue into the Venous Circulation. via openalex
- Natural Killer Cells: Key Players in Endometriosis via openalex
- Pathophysiology and Immune Dysfunction in Endometriosis via openalex
- Pelvic endometriosis and natural killer cell immunity via openalex
- Soluble HLA-G in the peritoneal fluid of women with endometriosis via openalex
- The expression of human leukocyte antigens class I and II in women with endometriosis or adenomyosis via openalex
- The Promises of Natural Killer Cell Therapy in Endometriosis via openalex
- W6604186803 via openalex
- W1966785366 via openalex
- W2053041715 via openalex
- W2135526902 via openalex
- W2184152595 via openalex
- W2300386653 via openalex
- W2339303388 via openalex
- W2402976159 via openalex
- W2477008945 via openalex
- W2810127666 via openalex
- W3016339115 via openalex
- W3097147331 via openalex
- W3123893780 via openalex
- W3146142859 via openalex
- W6603876847 via openalex
- W94644913 via openalex
Cited by (20)
- A Temporal Mechanism-Based Framework of Endometriosis Affecting Pregnancy Outcomes 2026
- The Microbiota–Endometriosis Axis: An Immune–Endocrine Integration Model and Emerging Therapeutic Targets 2026
- Urinary IL-1β and plasma IFN-γ levels reveal complementary immune mechanisms in endometriosis 2026
- Dysfunction of natural killer cells promotes immune escape and disease progression in endometriosis 2025
- Endometriosis and diet – can anti-inflammatory foods alleviate symptoms? 2025
- Reframing Endometriosis: Interplay of NETs, Macrophages, and Lymphocytes at the Crossroads of Disease Progression, Infertility, and Malignant Transformation 2025
- N-acetylcysteine stimulates organelle malfunction in endometriotic cells via IFN-gamma signaling 2025
- Creation of a rat model of ovarian endometriosis: a novel and easy approach to simulating chocolate cysts 2025
- PD-1 Expression in Endometriosis 2025
- Integrated bioinformatics analysis and machine learning identifies FZD4, SRPX2, and COL8A1 as angiogenesis hub genes in endometriosis 2025
- The Molecular and Cellular Mechanisms of Endometriosis: From Basic Pathophysiology to Clinical Implications 2025
- The interplay between endometriosis and obesity 2025
- TIM‐3 Expression in Endometriosis 2024
- A Comprehensive Review of Advanced Diagnostic Techniques for Endometriosis: New Approaches to Improving Women’s Well-Being 2024
- Changes in the number and activity of natural killer cells and its clinical association with endometriosis: systematic review and meta-analysis 2024
- Managing the neuroinflammatory pain of endometriosis in light of chronic pelvic pain 2024
- NK-92 cells activated by IL-2 inhibit the progression of endometriosis in vitro 2024
- Evaluation of the natural killer cell subsets and their relationship with serum interferon-gamma and vitamin D levels in women with stages III and IV endometriosis: A case-control study 2024
- Unraveling immunotherapeutic targets for endometriosis: a transcriptomic and single-cell analysis 2023
- ITRAQ-based proteomics analysis of human ectopic endometrial stromal cells treated by Maqian essential oil 2023
Source provenance
- europepmc
- last seen: 2026-06-04T01:30:01.192114+00:00
- openalex
- last seen: 2026-06-04T00:00:01.174412+00:00
- pubmed
- last seen: 2026-05-19T00:33:56.389617+00:00